.Attribute Medicine, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antibody-- medicine conjugate (ADC) tisotumab vedotin led to enhanced progression-free and also total survival, causing FDA commendation and a new procedure possibility for individuals.